Latest Institutional Placement News

Elevra Lithium has commenced construction on its North American Lithium expansion, backed by a recent capital raise that fully funds the project. The expansion aims to boost spodumene concentrate output by up to 20% and reduce operating costs by mid-2027.

Recce Pharmaceuticals secured A$4 million through an institutional placement and launched a Share Purchase Plan to raise up to an additional A$4 million, bolstering funds for commercial licensing and ongoing clinical programs.

Centuria Capital Group has launched the retail component of its $100 million entitlement offer, aiming to raise approximately $35 million. The equity raising supports expansion in AI infrastructure and real estate funds management.

KGL Resources has launched a A$300 million equity raising to complete funding for the Jervois Copper Project, combining it with a US$300 million streaming deal and existing cash to fully finance construction and production.

Centuria Capital Group has successfully secured $265 million through institutional placement and entitlement offers, setting the stage for a $35 million retail entitlement offer to follow.

Southern Cross Electrical Engineering (ASX:SXE) has launched a non-underwritten Share Purchase Plan targeting up to $15 million at $4.00 per share, matching its recent institutional placement price. The raise aims to support working capital for new projects and provide flexibility for future acquisitions.

Centuria Capital Group launches a $300 million fully underwritten equity raise to accelerate its AI Factory pipeline via ResetData and expand its real estate and credit funds platform.

ClearVue Technologies has secured A$6 million through a $5 million institutional placement and a fully underwritten $1 million Share Purchase Plan, aiming to bolster its balance sheet and fund international expansion and product development.

Lindian Resources has terminated its monazite concentrate sales agreement with Gerald Metals, issuing 20 million shares as part of the deal and reclaiming full control over its Kangankunde Rare Earths Project sales strategy.

Acrow Limited has secured $70 million through a fully underwritten two-tranche placement to acquire Ausgroup Industrial Services and Preston SuperDeck, boosting its FY27 revenue and EBITDA guidance significantly.

Vitrafy Life Sciences has launched a non-underwritten Share Purchase Plan to raise approximately A$2 million, offering existing Australian and New Zealand shareholders the chance to buy shares at A$2.60 each, matching the recent institutional placement price.

Acrow Limited (ASX:ACF) is set to expand its Industrial Access and Construction Services footprint with a $54.5 million acquisition of Ausgroup and Preston SuperDeck, funded by a fully underwritten $70 million equity raise and a $10 million share purchase plan. The company also upgraded its FY27 revenue and EBITDA guidance by 21% and 15% respectively.